Flanking HS-62.5 and 3' HS1, and regions upstream of the LCR, are not required for beta-globin transcription. 2006

M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. mbender@fhcrc.org

The locus control region (LCR) was thought to be necessary and sufficient for establishing and maintaining an open beta-globin locus chromatin domain in the repressive environment of the developing erythrocyte. However, deletion of the LCR from the endogenous locus had no significant effect on chromatin structure and did not silence transcription. Thus, the cis-regulatory elements that confer the open domain remain unidentified. The conserved DNaseI hypersensitivity sites (HSs) HS-62.5 and 3'HS1 that flank the locus, and the region upstream of the LCR have been implicated in globin gene regulation. The flanking HSs bind CCCTC binding factor (CTCF) and are thought to interact with the LCR to form a "chromatin hub" involved in beta-globin gene activation. Hispanic thalassemia, a deletion of the LCR and 27 kb upstream, leads to heterochromatinization and silencing of the locus. Thus, the region upstream of the LCR deleted in Hispanic thalassemia (upstream Hispanic region [UHR]) may be required for expression. To determine the importance of the UHR and flanking HSs for beta-globin expression, we generated and analyzed mice with targeted deletions of these elements. We demonstrate deletion of these regions alone, and in combination, do not affect transcription, bringing into question current models for the regulation of the beta-globin locus.

UI MeSH Term Description Entries
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D002843 Chromatin The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell. Chromatins
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D017384 Sequence Deletion Deletion of sequences of nucleic acids from the genetic material of an individual. Deletion Mutation,Deletion Mutations,Deletion, Sequence,Deletions, Sequence,Mutation, Deletion,Mutations, Deletion,Sequence Deletions

Related Publications

M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
March 1983, Cell,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
May 2010, The Journal of biological chemistry,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
January 2007, Blood cells, molecules & diseases,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
October 1998, Molecular cell,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
May 2001, Molecular and cellular biology,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
July 1998, Blood,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
January 1996, Molecular and cellular biology,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
April 2014, Nucleic acids research,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
July 1987, Nucleic acids research,
M A Bender, and Rachel Byron, and Tobias Ragoczy, and Agnes Telling, and Michael Bulger, and Mark Groudine
January 2009, Hemoglobin,
Copied contents to your clipboard!